Skip to main content

Table 1 Clinical and biochemical characteristics by study group

From: Macrophage migration inhibitory factor promoter polymorphisms (−794 CATT5–8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects

  Control group
(n = 186)
CHD group
(n = 70)
F/×2 P value
Mean age(year)a 60.78 ± 9.26 66.71 + 10.25 1.24 0.081
Ganderb
(male/female)
84/102 44/26 6.37 0.012
cigarette smoking(%)b 31.6% 33.3% 0.236 0.627
Drinking(%)b 18.3% 24.3% 0.677 0.41
Hypertension(%)b,c 66.7% 68.6% 0.054 0.817
Hyperlipidemia(%)b,d 16.7% 37.1% 6.76 0.009
Diabetes(%)b,e 3.3% 7.1% 0.92 0.337
  1. aData presented as mean ± SD. Student’s t-test
  2. bChi-square
  3. cblood pressure ≥ 140/90 mmHg
  4. dLDL-C ≥ 120mg/dl
  5. eFPG ≥ 7.0 mmol/l and/or OGTT 2 h FPG ≥ 11.1 mmol/l